ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) shares hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $16.60 and last traded at $16.74, with a volume of 1475997 shares traded. The stock had previously closed at $16.99. Wall Street Analyst Weigh In ACAD has been the […]
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) VP Meredith Cook sold 250 shares of ANI Pharmaceuticals stock in a transaction on Friday, April 12th. The shares were sold at an average price of $67.79, for a total value of $16,947.50. Following the transaction, the vice president now owns 59,731 shares in the company, valued […]
Needham & Company LLC reaffirmed their buy rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) in a research report released on Tuesday, Benzinga reports. They currently have a $32.00 target price on the biopharmaceutical company’s stock. Several other brokerages have also issued reports on ACAD. HC Wainwright reissued a buy rating and issued […]
ASLAN Pharmaceuticals Limited (NASDAQ:ASLN – Get Free Report) was the target of a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 116,800 shares, a drop of 59.8% from the March 15th total of 290,500 shares. Currently, 0.7% of the shares of the company are […]
StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note released on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Performance Shares of CASI Pharmaceuticals stock opened at $3.11 on Friday. CASI Pharmaceuticals has a one year low of $1.85 and […]